Aureomycin in the Treatment of Amebiasis
- 2 August 1950
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 243 (5) , 185-186
- https://doi.org/10.1056/nejm195008032430504
Abstract
IN THE long-continued search for amebicidal agents applicable to treatment of human infestations by Endamoeba histolytica, attention in the past year has been drawn to the apparent effectiveness of aureomycin. At the Veterans Administration Hospital in Lincoln, Nebraska, 20 patients with proved amebiasis have received aureomycin, and the results are believed to confirm those of other workers.McVay, Laird and Sprunt1 and Fuller and Faust2 first reported the apparent inhibitory action of aureomycin upon E. histolytica in vitro. McVay and his colleagues, Most3 and, more recently, Hughes4 administered aureomycin to patients with amebiasis and reported significant percentages of subsequently . . .Keywords
This publication has 5 references indexed in Scilit:
- TREATMENT OF AMEBIASIS WITH AUREOMYCINJAMA, 1950
- Aureomycin in the Cultivation of Endamoeba histolyticaScience, 1949
- CLINICAL EXPERIENCE WITH AUREOMYCIN 12Journal of Clinical Investigation, 1949
- A Preliminary Report of the Successful Treatment of Amebiasis with AureomycinScience, 1949
- RECENT ADVANCES IN THE THERAPY OF THE MORE COMMON PROTOZOAN AND HELMINTHIC INFECTIONS OF MAN1949